Keywords: sr, pharma, initiates, ph, rtp-801i, study, london

SR Pharma initiates Ph I RTP-801i study

Article | 12 February 2007

Print This

London, UK-based SR Pharma says that US collaboration partner Quark Biotech has started a Phase I clinical trial with RTP-801 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in